BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18458244)

  • 1. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis.
    Thomassin-Naggara I; Bazot M; Daraï E; Callard P; Thomassin J; Cuenod CA
    Radiology; 2008 Jul; 248(1):148-59. PubMed ID: 18458244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors.
    Thomassin-Naggara I; Daraï E; Cuenod CA; Rouzier R; Callard P; Bazot M
    J Magn Reson Imaging; 2008 Jul; 28(1):111-20. PubMed ID: 18581400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors.
    Li HM; Qiang JW; Ma FH; Zhao SH
    J Ovarian Res; 2017 Jan; 10(1):4. PubMed ID: 28088245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?
    Mansour SM; Saraya S; El-Faissal Y
    Br J Radiol; 2015 Sep; 88(1053):20150099. PubMed ID: 26083260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
    Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Masuda K; Toyoshima S; Kuroki S; Ohno S
    Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study.
    Taylor SA; Punwani S; Rodriguez-Justo M; Bainbridge A; Greenhalgh R; De Vita E; Forbes A; Cohen R; Windsor A; Obichere A; Hansmann A; Rajan J; Novelli M; Halligan S
    Radiology; 2009 May; 251(2):369-79. PubMed ID: 19276323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
    Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
    Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
    Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
    Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced cardiac MR imaging in the detection of reduced coronary flow velocity reserve.
    Barmeyer AA; Stork A; Muellerleile K; Tiburtius C; Schofer AK; Heitzer TA; Hofmann T; Adam G; Meinertz T; Lund GK
    Radiology; 2007 May; 243(2):377-85. PubMed ID: 17456867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study.
    Thomassin-Naggara I; Balvay D; Aubert E; Daraï E; Rouzier R; Cuenod CA; Bazot M
    Eur Radiol; 2012 Apr; 22(4):738-45. PubMed ID: 22105841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is dynamic gadolinium enhancement needed in MR imaging for the preoperative assessment of scaphoidal viability in patients with scaphoid nonunion?
    Donati OF; Zanetti M; Nagy L; Bode B; Schweizer A; Pfirrmann CW
    Radiology; 2011 Sep; 260(3):808-16. PubMed ID: 21712471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity.
    Horsthuis K; Lavini C; Bipat S; Stokkers PC; Stoker J
    Radiology; 2009 May; 251(2):380-7. PubMed ID: 19401571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience.
    Matuszewski L; Persigehl T; Wall A; Meier N; Bieker R; Kooijman H; Tombach B; Mesters R; Berdel WE; Heindel W; Bremer C
    Radiology; 2007 Jan; 242(1):217-24. PubMed ID: 17116730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
    Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
    Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
    Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
    Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy.
    van Rijswijk CS; Geirnaerdt MJ; Hogendoorn PC; Taminiau AH; van Coevorden F; Zwinderman AH; Pope TL; Bloem JL
    Radiology; 2004 Nov; 233(2):493-502. PubMed ID: 15459325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between benign and malignant colon tumors using fast dynamic gadolinium-enhanced MR colonography; a feasibility study.
    Achiam MP; Andersen LP; Klein M; Løgager V; Chabanova E; Thomsen HS; Rosenberg J
    Eur J Radiol; 2010 Jun; 74(3):e45-50. PubMed ID: 19419830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.